BRPI0409948A - composições de spex e processos de uso - Google Patents

composições de spex e processos de uso

Info

Publication number
BRPI0409948A
BRPI0409948A BRPI0409948-6A BRPI0409948A BRPI0409948A BR PI0409948 A BRPI0409948 A BR PI0409948A BR PI0409948 A BRPI0409948 A BR PI0409948A BR PI0409948 A BRPI0409948 A BR PI0409948A
Authority
BR
Brazil
Prior art keywords
spex
polypeptides
compositions
polynucleotides
compounds
Prior art date
Application number
BRPI0409948-6A
Other languages
English (en)
Inventor
Jonathan Kaye
Beverley Wilkinson
Original Assignee
Novartis Ag
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Scripps Research Inst filed Critical Novartis Ag
Publication of BRPI0409948A publication Critical patent/BRPI0409948A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"COMPOSIçõES DE SPEX E PROCESSOS DE USO". A presente invenção fornece novos polipeptídeos e outros fatores identificados como sendo expressos no tecido do baço e relacionados com a atividade de linfócitos e com a resposta imunológica. Estes compostos são referidos aqui como compostos SPEX. São fornecidos homólogos humanos e murinos de polipeptídeos e polinucleotídeos SPEX incluindo dois alelos murinos. A invenção fornece ainda polinucleotídeos que codificam os polipeptídeos e as seqüências de ácidos nucléicos complementares dos mesmos. Também são fornecidos imunógenos, vetores de expressão e anticorpos relacionados com os polipeptídeos e os polinucleotídeos SPEX. A presente invenção divulga o uso de anticorpos anti-SPEX na regulação da atividade de linfócitos e na regulação da resposta imunológica.
BRPI0409948-6A 2003-04-30 2004-04-29 composições de spex e processos de uso BRPI0409948A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46720603P 2003-04-30 2003-04-30
PCT/EP2004/004562 WO2004096976A2 (en) 2003-04-30 2004-04-29 Spex compositions and methods of use

Publications (1)

Publication Number Publication Date
BRPI0409948A true BRPI0409948A (pt) 2006-04-25

Family

ID=33418441

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409948-6A BRPI0409948A (pt) 2003-04-30 2004-04-29 composições de spex e processos de uso

Country Status (9)

Country Link
US (1) US20040248257A1 (pt)
EP (1) EP1622935A2 (pt)
JP (1) JP2006524489A (pt)
CN (1) CN1795205A (pt)
AU (1) AU2004234532A1 (pt)
BR (1) BRPI0409948A (pt)
CA (1) CA2523025A1 (pt)
MX (1) MXPA05011595A (pt)
WO (1) WO2004096976A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546541B2 (en) 2002-06-20 2013-10-01 Washington University Compositions and methods for modulating lymphocyte activity
WO2004000221A2 (en) * 2002-06-20 2003-12-31 The Regents Of The University Of California Compositions and methods for modulating lymphocyte activity
US7341843B2 (en) * 2003-04-11 2008-03-11 Allergan, Inc. Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
US8188232B1 (en) 2004-11-15 2012-05-29 Washington University In St. Louis Compositions and methods for modulating lymphocyte activity
WO2006063067A2 (en) * 2004-12-09 2006-06-15 La Jolla Institute For Allergy And Immunology Novel tnf receptor regulatory domain
US8349320B2 (en) 2004-12-09 2013-01-08 La Jolla Institute For Allergy And Immunology Compositions and methods for modulating responses mediated or associated with BTLA activity
US8303952B2 (en) 2009-06-08 2012-11-06 Washington University Methods for inducing in vivo tolerance
CN112877353B (zh) * 2021-01-19 2023-01-17 东北林业大学 一种表达载体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002502589A (ja) * 1998-02-09 2002-01-29 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４５個のヒト分泌タンパク質
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
WO2002072794A2 (en) * 2001-03-12 2002-09-19 Incyte Genomics, Inc. Immunoglobulin superfamily proteins
US20040097711A1 (en) * 2002-03-12 2004-05-20 Henry Yue Immunoglobulin superfamily proteins
WO2004000221A2 (en) * 2002-06-20 2003-12-31 The Regents Of The University Of California Compositions and methods for modulating lymphocyte activity
JP2006515167A (ja) * 2002-10-25 2006-05-25 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための新規組成物と方法

Also Published As

Publication number Publication date
WO2004096976A3 (en) 2005-04-07
MXPA05011595A (es) 2005-12-15
EP1622935A2 (en) 2006-02-08
JP2006524489A (ja) 2006-11-02
WO2004096976A2 (en) 2004-11-11
US20040248257A1 (en) 2004-12-09
AU2004234532A1 (en) 2004-11-11
CN1795205A (zh) 2006-06-28
CA2523025A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
BR0113921A (pt) ácidos nucléicos e polipeptìdeos receptores
BRPI0507489A (pt) anticorpos humanos de anti-cd38 e para os seus usos
BRPI0415613A (pt) novos compostos de diazaspiroalcanos e seu uso no tratamento de doenças mediadas por ccr8
DE69029934D1 (de) Aus dem gehirn stammender neurotropher faktor
BR9909860A (pt) Polipeptìdeos cd19xcd3 especìficos e usos dos mesmos
TR200100737T2 (tr) Osteoprotegerin ligand aktivitesini düzenleme yöntemi
EA200702093A1 (ru) Антитела-миметики glp-1 человека, композиции, способы и их применение
DE60028970D1 (de) An her2 bindende peptidverbindungen
DK0975595T3 (da) Kokainanaloger
BR0214553A (pt) Compostos, processo de preparação, em fase lìquida, dos compostos, e, composições farmacêuticas
BR0010716A (pt) Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
ATE89566T1 (de) Molekuele mit mindestens einer peptidsequenz einer oder mehrerer epitopen eines p.falciparum- produzierten proteins in hepatozyten und zusammensetzungen davon.
DK1590467T3 (da) Anvendelse af regulatoriske sekvenser til specifik, transient ekspression i neuronalt bestemte celler
BRPI0409948A (pt) composições de spex e processos de uso
DK0973794T3 (da) Netrinreceptorer
WO2001064877A3 (en) Human schizophrenia gene
WO1998011234A3 (en) Human protein kinases
NZ504025A (en) Vitamin D receptor related polypeptides (VDRR) and its use in treating inflammatory disease
ATE80912T1 (de) Menschliche proteine des chinolinesterase-typs und ihre herstellung.
BR0207327A (pt) Amino derivados de biotina e seus conjugados com agentes quelantes macrocìclicos
BR0007816A (pt) Fator de estimulação óssea
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.